The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

It reduces transmissions by up to 96%, but now world governments and big-dollar funders will need to step in.

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One looming question: Will it be affordable for lower resource countries?